Friday, July 30, 2021
wellness India Expo
Home Tags Drug

Tag: drug

Top 5 pharma majors collaborate to conduct clinical trial of anti-viral...

Cipla, Dr. Reddy’s, Emcure, Sun Pharma and Torrent to collaborate for clinical trial of investigational anti-viral drug Molnupiravir for COVID-19...........................

New drug for coronary diseases could be in offing

An agreement between CSIR-CDRI and Marc Laboratories could pave the way for developing a synthetic compound S-007-867 as modulator of blood coagulation cascade, in particular as inhibitor of collagen-induced platelet aggregation....................

Biotech startup, CyGenica secures USD $1.4 million funding from SOSV

The funding round will accelerate validation of CyGenica’s proprietary technology which enables safe, targeted and affordable intercellular drug delivery.............................

Cipla signs COVID-19 drug licensing deal with MSD

Cipla enters into a licensing agreement with MSD to expand access to the investigational oral therapeutic drug for COVID-19 treatment...........................

Mankind Pharma seeks CDSCO’s nod to conduct phase-1 clinical trials of...

A patented first in class novel anti-diabetic molecule, MKP10241 is a potent and orally administered small molecule, GPR119 agonist.........................

Indian scientists develop artificial enzyme to keep HIV virus in check

Made from vanadium pentoxide nanosheets, the new “nanozymes” work by mimicking the natural enzyme called glutathione peroxidase to help reduce oxidative stress levels in the host’s cells, which is required to keep the virus in check......................

IIT Guwahati partners NECHRI to identify novel biomarkers for cancer diagnosis,...

The collaboration enables research to identify cancer susceptible population from North East India....................

IIT-Indore scientists uncover a new approach to inhibit Zika virus replication

The COVID-19 pandemic has highlighted the threat posed by emerging and re-emerging diseases to public health across the world...................

Zydus to begin Phase I trials of its inflammation drug, ZYIL1

Phase I trial will study the safety, tolerability, pharmacokinetics and pharmacodynamics of ZYIL1 in healthy human volunteers. Zydus has secured a Strong IP portfolio with multiple patents filed in all major countries.....................

Syngene enters into 5-year strategic collaboration with Deerfield Discovery & Development

This five-year collaboration aims to advance therapeutic discovery projects, from target validation through to pharmacological proof of concept and preclinical evaluation.....................